Skip to main content
. 2020 Mar 31;11:451. doi: 10.3389/fmicb.2020.00451

TABLE 5.

Observed minimal inhibitory concentrations (MICs) (mg/L) or zone of inhibition diameter (ZD) (mm) of each antibiotic for the eight studied Serratia marcescens strains.

Antibiotics and Available Contemporary collection Historical collection
Resistance genes since MICs (mg/L) or ZD (mm)
MICs (mg/L) or ZD (mm)
O1-16 O7-16 O10-16 O11-16 4F-69 6F-69 13F-69 15F-69
Beta-lactams
Ampicillin 1961 >16 >16 >16 >16 >16 >16 >16 >16
Amoxicillin–Clavulanate 1972 >16/8 >16/8 >16/8 >16/8 >16/8 >16/8 >16/8 >16/8
Piperacillin–Tazobactam 1993 ≤8 ≤8 ≤8 ≤8 ≤8 >64 ≤8 ≤8
Cefazolin 1971 >16 >16 >16 >16 >16 >16 >16 >16
Cefuroxime 1978 >16 >16 >16 >16 >16 >16 >16 >16
Cefoxitin 1972 16 >16 >16 16 16 >16 16 16
Ceftazidime 1984 ≤1 ≤1 >16 ≤1 ≤1 >16 ≤1 ≤1
Cefotaxime 1980 ≤1 ≤1 >32 ≤1 ≤1 >32 ≤1 ≤1
Cefepime 1994 ≤1 ≤1 >16 ≤1 ≤1 8 ≤1 ≤1
Aztreonam 1986 ≤1 ≤1 >16 ≤1 ≤1 >16 ≤1 ≤1
Imipenem 1977 ≤1 ≤1 ≤1 ≤1 ≤1 ≤1 ≤1 ≤1
Ertapenem 2001 ≤0.5 ≤0.5 >4 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
Aminoglycosides
Gentamicin 1963 ≤2 ≤2 >8 ≤2 ≤2 ≤2 ≤2 ≤2
Tobramycin 1997 ≤2 ≤2 >8 ≤2 ≤2 4 4 ≤2
Amikacin 1976 ≤8 ≤8 >32 ≤8 ≤8 ≤8 ≤8 ≤8
Streptomycin* 1943 15 15 11 16 13 17 0 9
Ciprofloxacin 1987 ≤0.5 ≤0.5 1 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
Nalidixic acid 1965 ≤16 ≤16 >16 ≤16 ≤16 ≤16 ≤16 ≤16
TMP/SMX 1968-78 ≤2/38 ≤2/38 ≤2/38 ≤2/38 ≤2/38 ≤2/38 ≤2/38 ≤2/38
Tetracycline* 1953 14 12 15 13 21 21 0 12

MIC values or zone diameters over the clinical cutoff (based on EUCAST 2019 criteria) are highlighted in bold, underlined numbers. NA, not available; TMP/SMX, trimethoprim/sulfamethoxazole. Asterisk, antibiotics tested only by disk diffusion test (25 μg for streptomycin and 30 μg for tetracycline).